デオキシリボ核酸 (JP Patent Analysis Report)
The Technical Field "デオキシリボ核酸" had 71 patent application filings in the most recent period (2023-01-01 to 2023-04-30). This is a significantly decreased of -428 filings (-85.8%) over 499 they had in the same period of the previous year (2022-01-01 to 2022-04-30). This report also includes technical terms related to " DNA " in the search set.
The highest number of filings in 2017 with 2,078 cases, and their lowest number in 2023 with 134 cases.
The mean of the number of filings over the last 5 years (2019 to 2024, 7,290 cases in total) is 1,215, and the median is 1,642. The coefficient of variation (standard deviation/mean) is 0.7, and there have been relatively large fluctuations in the number of filings from year to year.
| Index | Value |
|---|---|
| Average | 1,215 patents |
| Std Dev | 818 |
| COV | 0.7 |
| Year | Cases | YOY |
|---|---|---|
| 2023 year | 134 cases | -91.1 % |
| 2022 year | 1,509 cases | -16.45 % |
| 2021 year | 1,806 cases | +1.69 % |
This report provides the latest patent analysis information (the IP landscape, including a patent map) on the patent search results of the JP patent database for デオキシリボ核酸 for the period of the last 10 years (2015-01-01 to 2024-12-31). You can compare the information in this report with the trends in your competitors’ patent filings and technologies, and use it to search for important patents.
This service provides, free of charge, a patent analysis report based on the latest patent data (Japanese, U.S., European, and PCT application publications) for use in patent searches, patent analysis, and IP landscaping. The service is offered by "Patent Integration" a firm specializing in patent search/patent analysis.
This report includes basic information to help you understand the IP strategy and management of デオキシリボ核酸, such as changes in the number of patents/patent applications they have filed, comparisons of the numbers of patents/patent applications filed by their peers and competitors, their top coapplicants (joint research partners, alliance partners), and their most important patents. It can be used in various intellectual property business operations such as IP landscaping, patent search/patent analysis, preparation of intellectual property business evaluation reports, selection of M&A candidates, and selection of alliance partners.
- Table of Contents
- Foreign Patent Analysis Report
- Patent Filing Summary for デオキシリボ核酸
- Search Set (Search Formula/Analysis Patents)
- Related Patent Analysis Report
- Competitors Information
- Top company Information
- • Information on Important Patents
- Provision of patent information to the media
- About this Site
He is a patent attorney at a patent office. He specializes in invention counseling, patent filing, and intellectual property strategies for start-up companies and new businesses in the fields of software, information technology and artificial intelligence. He runs a patent course for beginners on Udemy, an online course provider.
After studying physics at the University of Tokyo as a doctoral student, he was engaged in intellectual property analysis and technology trend research as an in-house patent attorney at a precision equipment manufacturer and at Toyota Central R&D Labs. Inc..
Introduction
The concept of the "IP landscape" (IPL) has been attracting attention recently.
An IP landscape is not limited to patent information, but also integrates and analyzes business information (e.g., non-patent information such as papers, news releases, stock information, and market information). Intellectual-property-based business management is realized through the analysis of intellectual property information applied to the formulation of management strategies and business strategies. This is a comprehensive approach that includes but not limited to planning of open and closed strategies, selecting M&A candidates, searching for alliance partners, and formulating intellectual property strategies, through the exploitation of intellectual property information.
IP landscaping usually includes patent search and patent analysis. In patent search and patent analysis, it is important to grasp the market position of each company and the overall technological trends and development trends for each technology. More specifically, it is important to understand what intellectual property your own company and other companies hold, what the strengths and weaknesses of other companies are, and how other companies are trying to exploit their intellectual property. In other words, it is important to understand both the business strategy and the intellectual property strategy of each company.
After reading this search report, you may be interested in more detailed patent searches and patent analysis. We offer a service called Patent Integration, which is an integrated patent search and patent analysis service. With reasonable pricing and a simple user interface such that even beginners can quickly search for and analyze patent information by company or technology from a web browser, please consider using it for detailed patent searches, patent analysis, and IP landscaping.
Patent Integration has a patent-landscaping function that can visually represent a set of tens of thousands of patents/patent applications. This allows you to convincingly show the technical positions of your company and its competitors to your management and business strategists in order to formulate management strategies and business strategies.
デオキシリボ核酸, Changes in the Number of JP Patents/Patent Applications
The changes in the number of patent filings of デオキシリボ核酸 over the last 20 years (JP) are shown below.
The change in the number of patents/patent applications is the most basic index in patent analysis. By examining the change in the number of patents/patent applications, you can see the status of technological development and R&D focus for each company or technology. It should be noted that since there is a one and a half year lag between the filing and the laying open of patent applications, it is not possible to analyze the situation more recently than one and half years prior to the present.
In this report, you can only see the change in the number of patents/patent applications by company or technology, whereas Patent Integration allows you to quickly compare the number of patent applications with your competitors in each technical field by cross-referencing with other keywords and patent classifications.
Search Set (Analysis Patents)
This patent analysis report was created for a patent search set of 14,964 cases retrieved by applying the following search formula and analysis period to the following patent database. Patent information such as a patent analysis result, a patent map, and a patent landscape can be freely used for patent searches, analysis, and work on intellectual property strategies, including IP landscaping.
デオキシリボ核酸
Same industry / competition company information (JP)
The number of patents and changes in the number of patents of other companies (competitors) in the same industry as デオキシリボ核酸 are shown below.
Comparison of changes in the number of patents with peers and competitors is an important analytical index for understanding the intellectual property strategies of each company. By checking the transition of the number of patents for each company / competitor, you can check the status of focus on technology development and R&D for each company / technology.
It should be noted that patents have a time lag of one and a half years from filing to publication, so it is not possible to analyze the situation more recent than one and a half years.
If you want to find out more information, " Patent Integration , You can compare the number of patent applications with competitors in each technical field in a short time by multiplying with other keywords and patent classifications.Please use it for more detailed patent information analysis such as selection of M&A candidate destinations and alliance destinations.
Trends in filing of joint patent applications in the last 3 years (2023 to 2025).
Comparing the number of applications of each company, 国立研究開発法人農業・食品産業技術総合研究機構 has the highest number of joint applications in the last in the last 3 years (2023 to 2025) with 14 cases, followed by 東洋紡株式会社 with 3 cases.
| Name | Cases |
|---|---|
| 国立研究開発法人農業・食品産業技術総合研究機構 | 14 cases |
| 東洋紡株式会社 | 3 cases |
| 株式会社日立製作所 | 2 cases |
| 国立研究開発法人産業技術総合研究所 | 1 cases |
| 国立研究開発法人理化学研究所 | 1 cases |
Trends in filing of joint patent applications for the target period (2015 to 2025).
Comparing the number of applications of each company, エフホフマン-ラロシュアーゲー has the highest number of joint applications in the last for the target period (2015 to 2025) with 255 cases, followed by ザリージェンツオブザユニバーシティオブカリフォルニア with 145 cases.
| Name | Cases |
|---|---|
| エフホフマン-ラロシュアーゲー | 255 cases |
| ザリージェンツオブザユニバーシティオブカリフォルニア | 145 cases |
| 東洋紡株式会社 | 108 cases |
| 国立研究開発法人農業・食品産業技術総合研究機構 | 95 cases |
| ジェネンテックインコーポレイテッド | 78 cases |
| 国立研究開発法人産業技術総合研究所 | 56 cases |
| 国立研究開発法人理化学研究所 | 50 cases |
| 株式会社日立製作所 | 31 cases |
| 武田薬品工業株式会社 | 18 cases |
| 味の素株式会社 | 17 cases |
| 国立研究開発法人科学技術振興機構 | 12 cases |
Same industry / competition company, Change in the Number of JP Patents
Below is a patent map showing changes in the number of applications for JP patents of 11 companies in the same industry over the past 20 years.
Top company information (JP)
The number of patents and changes in the number of patents of other companies (competitors) in the same industry as デオキシリボ核酸 are shown below.
Comparison of changes in the number of patents with peers and competitors is an important analytical index for understanding the intellectual property strategies of each company. By checking the transition of the number of patents for each company / competitor, you can check the status of focus on technology development and R&D for each company / technology.
It should be noted that patents have a time lag of one and a half years from filing to publication, so it is not possible to analyze the situation more recent than one and a half years.
If you want to find out more information, " Patent Integration , You can compare the number of patent applications with competitors in each technical field in a short time by multiplying with other keywords and patent classifications.Please use it for more detailed patent information analysis such as selection of M&A candidate destinations and alliance destinations.
Trends in filing of joint patent applications in the last 3 years (2023 to 2025).
Among the top coapplicants, 東洋紡株式会社 has the highest number of joint applications in the last in the last 3 years (2023 to 2025) with 3 cases, followed by 国立研究開発法人産業技術総合研究所 with 1 cases.
| Name | Cases |
|---|---|
| 東洋紡株式会社 | 3 cases |
| 国立研究開発法人産業技術総合研究所 | 1 cases |
| 国立研究開発法人理化学研究所 | 1 cases |
Trends in filing of joint patent applications for the target period (2015 to 2025).
Among the top coapplicants, エフホフマン-ラロシュアーゲー has the highest number of joint applications in the last for the target period (2015 to 2025) with 255 cases, followed by 東洋紡株式会社 with 108 cases.
| Name | Cases |
|---|---|
| エフホフマン-ラロシュアーゲー | 255 cases |
| 東洋紡株式会社 | 108 cases |
| 国立研究開発法人産業技術総合研究所 | 56 cases |
| 国立研究開発法人理化学研究所 | 50 cases |
| 武田薬品工業株式会社 | 18 cases |
| 味の素株式会社 | 17 cases |
| 国立研究開発法人科学技術振興機構 | 12 cases |
Top company, Change in the Number of JP Patents
Below is a ranking of the number of JP patent applications by デオキシリボ核酸’s top 7 coapplicants over the last 20 years.
Below is a patent map showing the changes in the numbers of JP patent filings by デオキシリボ核酸’s top 7 coapplicants over the last 20 years.
Top company Details (JP)
Trends in filing of joint patent applications with 国立研究開発法人科学技術振興機構
デオキシリボ核酸 filed 12 joint applications with 国立研究開発法人科学技術振興機構 for the analysis period (2015 to 2025).
The mean of the number of filings over the last 5 years (2019 to 2024, 7 cases in total) is 1.2, and the median is 0.5. The coefficient of variation (standard deviation/mean) is 1.5, and there have been very big fluctuations in the number of filings from year to year.
The highest number of filings in 2015 with 5 cases, and their lowest number in 2023 with 0 cases.
| Index | Value |
|---|---|
| Average | 1.2 patents |
| Std Dev | 1.8 |
| COV | 1.5 |
| Year | Cases | YOY |
|---|---|---|
| 2022 year | 1 cases | - |
| 2021 year | 0 cases | -100 % |
| 2020 year | 5 cases | +400 % |
Trends in filing of joint patent applications with 国立研究開発法人産業技術総合研究所
デオキシリボ核酸 filed 56 joint applications with 国立研究開発法人産業技術総合研究所 for the analysis period (2015 to 2025).
The mean of the number of filings over the last 5 years (2019 to 2024, 20 cases in total) is 3.3, and the median is 3.5. The coefficient of variation (standard deviation/mean) is 0.7, and there have been relatively large fluctuations in the number of filings from year to year.
The highest number of filings in 2015 with 10 cases, and their lowest number in 2023 with 1 cases.
| Index | Value |
|---|---|
| Average | 3.3 patents |
| Std Dev | 2.4 |
| COV | 0.7 |
| Year | Cases | YOY |
|---|---|---|
| 2023 year | 1 cases | -75.0 % |
| 2022 year | 4 cases | -20.00 % |
| 2021 year | 5 cases | -28.57 % |
Trends in filing of joint patent applications with 武田薬品工業株式会社
デオキシリボ核酸 filed 18 joint applications with 武田薬品工業株式会社 for the analysis period (2015 to 2025).
The mean of the number of filings over the last 5 years (2019 to 2024, 7 cases in total) is 1.2, and the median is 1.0. The coefficient of variation (standard deviation/mean) is 0.9, and there have been relatively large fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2021 to 2024). The highest number of filings in 2018 with 6 cases, and their lowest number in 2023 with 0 cases.
| Index | Value |
|---|---|
| Average | 1.2 patents |
| Std Dev | 1.1 |
| COV | 0.9 |
| Year | Cases | YOY |
|---|---|---|
| 2022 year | 1 cases | -66.7 % |
| 2021 year | 3 cases | +50.0 % |
| 2020 year | 2 cases | +100 % |
Trends in filing of joint patent applications with エフホフマン-ラロシュアーゲー
デオキシリボ核酸 filed 255 joint applications with エフホフマン-ラロシュアーゲー for the analysis period (2015 to 2025).
The mean of the number of filings over the last 5 years (2019 to 2024, 137 cases in total) is 22.8, and the median is 21.5. The coefficient of variation (standard deviation/mean) is 0.9, and there have been relatively large fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2021 to 2024). The highest number of filings in 2019 with 47 cases, and their lowest number in 2023 with 0 cases.
| Index | Value |
|---|---|
| Average | 22.8 patents |
| Std Dev | 19.6 |
| COV | 0.9 |
| Year | Cases | YOY |
|---|---|---|
| 2022 year | 15 cases | -46.4 % |
| 2021 year | 28 cases | -40.4 % |
| 2020 year | 47 cases | 0 |
Trends in filing of joint patent applications with 東洋紡株式会社
デオキシリボ核酸 filed 108 joint applications with 東洋紡株式会社 for the analysis period (2015 to 2025).
The mean of the number of filings over the last 5 years (2019 to 2024, 56 cases in total) is 9.3, and the median is 10.0. The coefficient of variation (standard deviation/mean) is 0.7, and there have been relatively large fluctuations in the number of filings from year to year.
The highest number of filings in 2019 with 20 cases, and their lowest number in 2023 with 2 cases.
| Index | Value |
|---|---|
| Average | 9.3 patents |
| Std Dev | 6.5 |
| COV | 0.7 |
| Year | Cases | YOY |
|---|---|---|
| 2023 year | 2 cases | -80.0 % |
| 2022 year | 10 cases | -23.08 % |
| 2021 year | 13 cases | +30.0 % |
Information on important patents (JP)
The following shows JP patents held by デオキシリボ核酸 that have had an invalidation trial against them demanded or an opposition filed against them by a third party, and デオキシリボ核酸’s JP patents/patent applications of high importance cited by Examiners in patent examination processes.
By noting the most important patents, you can obtain knowledge of the competitive business environment in which デオキシリボ核酸 is placed (e.g., whether it is a fiercely competitive environment or an oligopolistic market and the like). In general, it can be understood that a company with a large number of demands for invalidation trials is developing their business in a business environment where IP disputes are common.
If you want to search for more detailed information, you can use Patent Integration to retrieve and download by company cited patents/patent applications or patents undergoing invalidation trials. You can quickly extract important patents from a patent set that includes multiple competitors by cross-referencing with other keywords and patent classifications. Please consider using it for searches for important patents/patent applications.
Glossary
- Cited
- Indicates that the patent/patent application has been cited (by Examiners) in notices of reasons for rejection in the examination process of other (Japanese, U.S., or European) patent applications. The higher the number of citations, the more important the patent/patent application is considered to be.
- Request for invalidation trial
- Indicates that a third party has requested a procedure to invalidate the patent. It is likely to affect the business of third parties and is considered to be of high importance.
- Opposition
- Indicates that a third party has filed a petition with the Patent Office to hear the validity of the patent again. Like the trial for invalidation, it is considered to be of high importance.
- Information provision
- Indicates that a third party has provided the Patent Office with useful information for examination for the patent filed. It is usually considered to be of high importance because it is done to prevent the patent from being granted.
- Browsing request
- Indicates that a third party has requested the Patent Office to view the patent bag (a set of documents exchanged between the Patent Office and the applicant). The bag is often checked prior to trial for invalidation, opposition, and provision of information, and is considered to be a highly important patent.
Invalidationed Trial cases
List of latest Invalidationed Trial patents
In the last 3 years (2022-01-01 ~ 2024-12-31), there were 4 patents Invalidation Trial from third parties. The average number of Invalidation Trial is 1.0 times. The most recently Invalidation Trial patent is 特許6814997 "５’キャップ付ＲＮＡを合成するための組成物および方法" (Invalidation Trial day 2024-05-15) , next is 特許7016341 "ＰＤ－１軸結合アンタゴニスト及びＴＩＧＩＴ阻害剤を使用するがんの治療方法" (Invalidation Trial day 2023-03-27) .
| - | No. | Title | Invalidation Trial days |
|---|---|---|---|
| 1 | 特許6814997 | ５’キャップ付ＲＮＡを合成するための組成物および方法 | 2024-05-15 |
| 2 | 特許7016341 | ＰＤ－１軸結合アンタゴニスト及びＴＩＧＩＴ阻害剤を使用するがんの治療方法 | 2023-03-27 |
| 3 | 特許6896700 | ワクチン組成物 | 2023-01-27 |
| 4 | 特許6692856 | ＲＮＡ依存性標的ＤＮＡ修飾およびＲＮＡ依存性転写調節のための方法および組成物 | 2022-02-25 |
Top Patents/Patent Applications with the Highest Number of Invalidationed Trial
Of the patent applications filed in the last 10 years (2015-01-01 to 2024-12-31), 2 patents/patent applications were invalidation trial more than once in the examination process of other patent applications. The mean of the number of invalidation trial is 1.0. The most invalidation trial patent is 特許6814997 "５’キャップ付ＲＮＡを合成するための組成物および方法" (1 times) , and the next most invalidation trial patent is 特許6896700 "ワクチン組成物" (1 times) .
| - | No. | Title | |
|---|---|---|---|
| 1 | 特許6814997 | ５’キャップ付ＲＮＡを合成するための組成物および方法 | 1 times |
| 2 | 特許6896700 | ワクチン組成物 | 1 times |
Oppositioned cases
List of latest Oppositioned patents
In the last 3 years (2022-01-01 ~ 2024-12-31), there were 13 patents Opposition from third parties. The average number of Opposition is 1.0 times. The most recently Opposition patent is 特許7433217 "ＲＮＡウイルスの処理方法" (Opposition day 2024-08-15) , next is 特許7430358 "ＤＮＡが編集された真核細胞を製造する方法、および当該方法に用いられるキット" (Opposition day 2024-08-09) .
| - | No. | Title | Opposition days |
|---|---|---|---|
| 1 | 特許7433217 | ＲＮＡウイルスの処理方法 | 2024-08-15 |
| 2 | 特許7430358 | ＤＮＡが編集された真核細胞を製造する方法、および当該方法に用いられるキット | 2024-08-09 |
| 3 | 特許7448953 | 眼疾患のための細胞モデル及び治療関連出願への相互参照 | 2024-04-17 |
| 4 | 特許7301332 | ＤＮＡが編集された真核細胞を製造する方法、および当該方法に用いられるキット | 2024-01-04 |
| 5 | 特許7289655 | ＰＡＭＰＳ及びＤＡＭＰＳの除去への血液適合性多孔性ポリマービーズ吸着剤の使用 | 2023-12-12 |
| 6 | 特許7244922 | 化学修飾された一本鎖ＲＮＡ編集オリゴヌクレオチド | 2023-09-20 |
| 7 | 特許7188087 | 一本鎖オリゴヌクレオチド | 2023-06-12 |
| 8 | 特許7180935 | 液状飲料組成物 | 2023-05-25 |
| 9 | 特許7089003 | ＲＮＡの免疫原性を低減するための方法 | 2022-12-19 |
| 10 | 特許7078812 | ＲＮＡの免疫原性を低減するための方法 | 2022-12-01 |
Protested cases
List of latest Protested patents
In the last 3 years (2022-01-01 ~ 2024-12-31), there were 32 patents Protest from third parties. The average number of Protest is 1.2 times. The most recently Protest patent is 特開2023-032890 "細胞質雄性不稔性遺伝子、雄性不稔回復植物、ナス科植物の細胞質雄性不稔の稔性を回復する方法、雄性不稔回復植物の製造方法、雄性不稔性植物、及び雄性不稔性植物の製造方法" (Protest day 2024-11-29) , next is 特表2023-510911 "卵巣癌を検出するための組成物及び方法" (Protest day 2024-10-11) .
| - | No. | Title | Protest days |
|---|---|---|---|
| 1 | 特開2023-032890 | 細胞質雄性不稔性遺伝子、雄性不稔回復植物、ナス科植物の細胞質雄性不稔の稔性を回復する方法、雄性不稔回復植物の製造方法、雄性不稔性植物、及び雄性不稔性植物の製造方法 | 2024-11-29 |
| 2 | 特表2023-510911 | 卵巣癌を検出するための組成物及び方法 | 2024-10-11 |
| 3 | 特表2023-512075 | オリゴヌクレオチドを特徴解析するための液体クロマトグラフィーおよび質量分析の使用 | 2024-10-04 |
| 4 | 特表2023-501219 | ＬＡＭＰ及びプローブ検出を使用する核酸検出法 | 2024-09-17 |
| 5 | 特開2024-028649 | ＤＮＡが編集された真核細胞を製造する方法、および当該方法に用いられるキット | 2024-08-28 |
| 6 | 特表2023-517644 | コロナウイルスワクチン組成物及び方法 | 2024-06-15 |
| 7 | 特許7527665 | トルコギキョウ植物を判別する方法、作出する方法、及びトルコギキョウ植物 | 2024-05-15 |
| 8 | 特表2022-531876 | オリゴヌクレオチドの収束液相合成 | 2024-05-09 |
| 9 | 特表2022-518510 | 薬物耐性ＭＹＣＯＰＬＡＳＭＡ ＧＥＮＩＴＡＬＩＵＭの検出 | 2024-03-13 |
| 10 | 特開2023-055917 | ＰＡＭＰＳ及びＤＡＭＰＳの除去への血液適合性多孔性ポリマービーズ吸着剤の使用 | 2024-01-17 |
| 11 | 特許7428991 | 糖の吸収抑制用剤 | 2023-11-10 |
| 12 | 特許7532752 | 改良されたウイルス検出方法 | 2023-11-06 |
| 13 | 特許7516731 | 改良されたウイルス検出方法 | 2023-11-06 |
| 14 | 特許7433217 | ＲＮＡウイルスの処理方法 | 2023-08-08 |
| 15 | 特開2021-169432 | 手指消毒剤 | 2023-08-04 |
| 16 | 特許7392309 | 改良されたウイルス検出方法 | 2023-07-25 |
| 17 | 特表2021-503278 | ＣａｓＺ組成物及び使用方法 | 2023-07-06 |
| 18 | 特表2022-536157 | 改変された酸化プロトコルを使用してオリゴヌクレオチドを調製するための方法 | 2023-04-27 |
| 19 | 特許7524214 | 抗体コード配列をセーフハーバー遺伝子座に挿入するための方法および組成物 | 2023-03-24 |
| 20 | 特開2020-115777 | 改良された核酸検出方法 | 2023-03-13 |
Top Patents/Patent Applications with the Highest Number of Protested
Of the patent applications filed in the last 10 years (2015-01-01 to 2024-12-31), 59 patents/patent applications were protest more than once in the examination process of other patent applications. The mean of the number of protest is 1.2. The most protest patent is 特許6975516 "外用組成物、化粧料、経皮吸収促進用組成物、外用組成物における有効成分の経皮吸収性を高める方法、経皮投与型医薬及び点眼用組成物" (3 times) , and the next most protest patent is 特許6994730 "ゲノム編集タンパク質の直接導入による糸状菌ゲノム編集方法" (3 times) .
| - | No. | Title | |
|---|---|---|---|
| 1 | 特許6975516 | 外用組成物、化粧料、経皮吸収促進用組成物、外用組成物における有効成分の経皮吸収性を高める方法、経皮投与型医薬及び点眼用組成物 | 3 times |
| 2 | 特許6994730 | ゲノム編集タンパク質の直接導入による糸状菌ゲノム編集方法 | 3 times |
| 3 | 特表2021-524495 | 酸化的ストレスおよびミトコンドリアストレスから，細胞を保護する組成物 | 3 times |
| 4 | 特許6872307 | ホウレンソウにおけるペロノスポラ耐性のための組成物及び方法 | 2 times |
| 5 | 特許6640267 | エンドトキシン測定剤 | 2 times |
Inspectioned cases
List of latest Inspectioned patents
In the last 3 years (2022-01-01 ~ 2024-12-31), there were 231 patents Inspection from third parties. The average number of Inspection is 1.2 times. The most recently Inspection patent is 特表2021-503278 "ＣａｓＺ組成物及び使用方法" (Inspection day 2024-12-24) , next is 特表2022-512593 "抗原提示細胞の機能を増強するための生体分子の細胞内送達" (Inspection day 2024-12-19) .
| - | No. | Title | Inspection days |
|---|---|---|---|
| 1 | 特表2021-503278 | ＣａｓＺ組成物及び使用方法 | 2024-12-24 |
| 2 | 特表2022-512593 | 抗原提示細胞の機能を増強するための生体分子の細胞内送達 | 2024-12-19 |
| 3 | 特開2023-027278 | 試薬チャネル混合システム及び試薬チャネル混合方法 | 2024-12-19 |
| 4 | 特表2024-502755 | がんを処置する方法 | 2024-12-18 |
| 5 | 特表2022-517952 | 分子エレクトロニクスのための伝導性合成ペプチド | 2024-12-18 |
| 6 | 特開2022-141855 | 核酸の標準化された配列決定のための方法およびその使用 | 2024-12-17 |
| 7 | 特開2023-085281 | 扱いにくい試料タイプのための試料調製 | 2024-12-13 |
| 8 | 特表2021-525549 | 腫瘍特異的ネオ抗原およびその使用方法 | 2024-12-04 |
| 9 | 特表2022-516318 | カプセル化ポリヌクレオチド及び使用方法 | 2024-11-22 |
| 10 | 特表2022-517456 | 臓器健康および疾患をモニタリングするための方法およびシステム | 2024-11-21 |
| 11 | 特表2022-514116 | 新規な癌抗原及び方法 | 2024-11-21 |
| 12 | 特開2022-097486 | ｍＲＮＡの機能状態を変化させてその選択的かつ特異的な認識を可能にする方法 | 2024-11-14 |
| 13 | 特開2023-123469 | Ｂ型肝炎ウイルス感染のためのＲＮＡｉ薬 | 2024-11-06 |
| 14 | 特表2024-532689 | ヒドロキシエチルでキャップされたカチオン性ペプトイドを含む組成物 | 2024-11-06 |
| 15 | 特表2022-504139 | バイオフィルムの除去のためのＨＭＧＢ１タンパク質誘導体 | 2024-11-05 |
| 16 | 特表2022-538609 | 新規な癌抗原及び方法 | 2024-10-30 |
| 17 | 特開2022-115923 | 逐次ハイブリダイゼーションバーコーディングによる分子の多重標識化 | 2024-10-29 |
| 18 | 特表2022-537570 | がんを処置する方法 | 2024-10-23 |
| 19 | 特表2023-501219 | ＬＡＭＰ及びプローブ検出を使用する核酸検出法 | 2024-10-18 |
| 20 | 特開2024-156659 | 単分子センサアレイを用いたハイスループット核酸配列決定 | 2024-10-17 |
Top Patents/Patent Applications with the Highest Number of Inspectioned
Of the patent applications filed in the last 10 years (2015-01-01 to 2024-12-31), 468 patents/patent applications were inspection more than once in the examination process of other patent applications. The mean of the number of inspection is 1.2. The most inspection patent is 特表2021-524495 "酸化的ストレスおよびミトコンドリアストレスから，細胞を保護する組成物" (8 times) , and the next most inspection patent is 特許6426670 "真核生物細胞を改変する方法" (6 times) .
| - | No. | Title | |
|---|---|---|---|
| 1 | 特表2021-524495 | 酸化的ストレスおよびミトコンドリアストレスから，細胞を保護する組成物 | 8 times |
| 2 | 特許6426670 | 真核生物細胞を改変する方法 | 6 times |
| 3 | 特開2018-203628 | 化粧料組成物又は飲食品組成物 | 6 times |
| 4 | 特許6402368 | 真核生物細胞を改変する方法 | 6 times |
| 5 | 特開2016-155809 | 狭窄病変および血栓溶解療法のための剪断による制御放出 | 5 times |
Cited cases
Top Patents/Patent Applications with the Highest Number of Cited
Of the patent applications filed in the last 10 years (2015-01-01 to 2024-12-31), 2,031 patents/patent applications were cited more than once in the examination process of other patent applications. The mean of the number of cited is 2.2. The most cited patent is 特許6099228 "食品製品の提供方法" (54 times) , and the next most cited patent is 特許7185009 "細胞トランスフェクションのエレクトロポレーション装置及び方法" (39 times) .
| - | No. | Title | |
|---|---|---|---|
| 1 | 特許6099228 | 食品製品の提供方法 | 54 times |
| 2 | 特許7185009 | 細胞トランスフェクションのエレクトロポレーション装置及び方法 | 39 times |
| 3 | 特許6395765 | 配列操作のための改善された系、方法および酵素組成物のエンジニアリングおよび最適化 | 36 times |
| 4 | 特許6196343 | 免疫グロブリンに特異的に結合するタンパク質および免疫グロブリン結合性アフィニティーリガンド | 36 times |
| 5 | 特許6429337 | ミドリイシ属サンゴのための種間及び種内マイクロサテライトマーカー | 33 times |
Providing patent information to the media (newspapers, magazines, etc.)
"Patent Integration Report" is a web service provided by "Patent Integration Co., Ltd." operated by patent attorneys who are experts in intellectual property rights. Based on the latest patent data, this is one of the largest patent report services in Japan that provides information on technology trends in various companies and technology fields.
The purpose of this web service is to make intellectual property information familiar to many people, regardless of whether they have an interest in intellectual property rights, and to make use of it.
We actively provide various types of patent information that can be used in various media articles such as newspapers, magazines, and web media. Please feel free to contact us from "Inquiry form for details on the content of patent information that can be provided, conditions for provision, etc. Please contact us.
About this Site
All rights related to the data, documents and charts belong to "an integrated patent search/analysis service provider, Patent Integration". Please specify the source “Patent Integration Report, URL: https://patent-i.com/report/en/" when inserting them into in-house materials, external report materials, etc., regardless of whether they are paid or free of charge.
Patent data is obtained by aggregating and analyzing the latest patent data issued by the Patent Offices of respective countries and jurisdictions and by WIPO. Although we take great care in publishing and analyzing the results, we do not guarantee the correctness of the data. We appreciate your understanding.
If you have any concerns about this service, please feel free to contact us.
All rights to the data, documents, figures and tables are reserved by e-Patent. When publishing internal documents, external reports, etc. (whether paid or free of charge), please use the following URL: https://e-patent.co.jp/.
Please note the following points for use.
e-Patent will not be liable for any damages or losses arising from the use of the global patent application status, ranking information, or population search formula in the "SDGs Global Company Ranking from a Patent Perspective". Items with ● in front of the target are not supported at this time (judged to be difficult to approach from the patent information analysis).
Citation of patent application status and ranking information
There is no problem to cite patent application status and ranking information, but please clearly indicate "Source: e-Patent Co.
Graphs are image data.
Please note that the various graphs are image data, but we cannot provide them in text data.Scope of coverage for each goal/target
- Based on the description of each goal and target of the SDGs, we have set the scope of technologies to be covered based on our and e-Patent's past experience, etc. (in some cases, the search is based on social issues themselves). Therefore, please note that there is a possibility that this "SDGs Global Company Ranking from Patent Perspective" may not cover 100%.
- A population search formula is clearly indicated for each goal/target (database: Patent Integration). You may use the population search formula as it is, or you may improve it by yourself.
- This search covers patents and utility models, including both published and registered patents (design and design patents are excluded). The unit of count is the number of applications, not the number of patent families.
About the name collation and name control of applicants and right holders
- Company rankings are based on the results calculated by "Patent Integration", with Japanese organizations in Japanese and other companies in English (some are in Japanese).
- Company names may be the names of the companies at the time of application, but the results calculated by Patent Integration are used as is. Company names are used as they were at the time of application.
- Because of the fluctuation in the names of companies (i.e., applicant/right holder names in the patent information), there are cases where the same company appears more than once in the top 10. The number of applications filed by the same company in the top 10 is the total number of applications filed by the company.
Credit notation
・MeCab user dictionary for science technology term © National Bioscience Database Center licensed under CC Attribution-Share Alike 4.0 International
Our Commitment to Safety and Security
Patent Integration Co., Ltd. is committed to providing high-quality patent information based on the latest patent data on more than 45 million cases collected from the Patent Offices in Japan, the U.S., Europe, and Taiwan and from PCT publication. 
Patent Integration Co., Ltd. collects the patent data from the Patent Offices in Japan, the U.S., Europe, and Taiwan and from PCT publications to provide it widely in the form of reports so that anyone can check patent information and patent trends with confidence. 
Patent Integration Co., Ltd. is committed to various efforts to enhance the reliability of the information and to allow users to search patent information with confidence.